Compound details
Kaempferol 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside]
| Compound ID | CDAMM00901 |
|---|---|
| Common name | Kaempferol 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside] | IUPAC name | 5-[[5-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid |
| Molecular formula | C33H38O19 |
| Retention time | 0.36 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 739.211 | Theoretical mz | 739.208 |
| Error | 3.41 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.2128 |
| Inchi key | XFTBRZGXKCHGKC-HLUKUQNVNA-N |
|---|---|
| Smiles | O=C(O)CC(O)(C)CC(=O)OCC1OC(OC=2C(=O)C3=C(O)C=C(OC)C=C3OC2C=4C=CC(O)=CC4)C(OC5OCC(O)(CO)C5O)C(O)C1O |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |